[Use of ustekinumab in inflammatory bowel disease: apropos of three cases].
Cristina
C
Pisabarros Blanco
Begoña
B
Alvarez Cuenllas
Maria
M
Garcia Alvarado
Luis
L
Vaquero
Elvira
E
del Pozo Maroto
Aleida
A
de Miguel
Mónica
M
Sierra Ausin
Fernando
F
Muñoz Nuñez
D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D003424:Crohn Disease / Q000188:drug therapy*; D004351:Drug Resistance; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D053762:Interleukin-12 Subunit p40 / Q000037:antagonists & inhibitors / Q000276:immunology; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D000069549:Ustekinumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; D053762:Interleukin-12 Subunit p40; D000069549:Ustekinumab